Cargando…
Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia
BACKGROUND: Despite the availability of numerous antipsychotic medications, many patients with schizophrenia continue to experience side effects that contribute to the overall burden of the illness. The present survey of patients with schizophrenia and schizoaffective disorder aimed to assess patien...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142379/ https://www.ncbi.nlm.nih.gov/pubmed/30223804 http://dx.doi.org/10.1186/s12888-018-1856-y |
_version_ | 1783355847554891776 |
---|---|
author | Achtyes, Eric Simmons, Adam Skabeev, Anna Levy, Nikki Jiang, Ying Marcy, Patricia Weiden, Peter J. |
author_facet | Achtyes, Eric Simmons, Adam Skabeev, Anna Levy, Nikki Jiang, Ying Marcy, Patricia Weiden, Peter J. |
author_sort | Achtyes, Eric |
collection | PubMed |
description | BACKGROUND: Despite the availability of numerous antipsychotic medications, many patients with schizophrenia continue to experience side effects that contribute to the overall burden of the illness. The present survey of patients with schizophrenia and schizoaffective disorder aimed to assess patient attitudes toward antipsychotic treatment, and understand key factors about willingness to try a new medication. METHODS: A cross-sectional survey was administered to 250 patients with a primary clinical diagnosis of a schizophrenia spectrum disorder across five outpatient clinics in the United States. The survey included self-reported gender, age, weight, and height, and questions about the importance of efficacy and side effects on the decision to take a prescribed antipsychotic medication. RESULTS: Patients rated efficacy and side effects as important attributes of antipsychotic treatment, with 93.6% and 83.6% of patients listing these as “very” or the “most” important factors in taking prescribed medication. A total of 87.6% of respondents identified the ability to think more clearly as an important property of their medication. Patients identified weight gain, physical restlessness, and somnolence as important side effects of current treatments (“very” or “most” important by 61.6%, 60.8%, and 58.8%, respectively). When asked about willingness to change antipsychotic medication, anticipated weight gain had a negative influence on willingness to try the new treatment, with 22.0% declining to try a medication that would lead to weight gain of 2.7–4.5 kg (6–10 lb), 34.0% declining for anticipated weight gain of 5.0–9.1 kg (11–20 lb), and 52.4% declining for anticipated weight gain greater than 9 kg (20 lbs). CONCLUSION: Patients living with schizophrenia spectrum disorders are influenced by many factors when considering whether to take their medication, including efficacy and side effects. It is important for clinicians to assess specific patient concerns to develop a comprehensive treatment plan that maximizes adherence to the prescribed therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12888-018-1856-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6142379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61423792018-09-20 Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia Achtyes, Eric Simmons, Adam Skabeev, Anna Levy, Nikki Jiang, Ying Marcy, Patricia Weiden, Peter J. BMC Psychiatry Research Article BACKGROUND: Despite the availability of numerous antipsychotic medications, many patients with schizophrenia continue to experience side effects that contribute to the overall burden of the illness. The present survey of patients with schizophrenia and schizoaffective disorder aimed to assess patient attitudes toward antipsychotic treatment, and understand key factors about willingness to try a new medication. METHODS: A cross-sectional survey was administered to 250 patients with a primary clinical diagnosis of a schizophrenia spectrum disorder across five outpatient clinics in the United States. The survey included self-reported gender, age, weight, and height, and questions about the importance of efficacy and side effects on the decision to take a prescribed antipsychotic medication. RESULTS: Patients rated efficacy and side effects as important attributes of antipsychotic treatment, with 93.6% and 83.6% of patients listing these as “very” or the “most” important factors in taking prescribed medication. A total of 87.6% of respondents identified the ability to think more clearly as an important property of their medication. Patients identified weight gain, physical restlessness, and somnolence as important side effects of current treatments (“very” or “most” important by 61.6%, 60.8%, and 58.8%, respectively). When asked about willingness to change antipsychotic medication, anticipated weight gain had a negative influence on willingness to try the new treatment, with 22.0% declining to try a medication that would lead to weight gain of 2.7–4.5 kg (6–10 lb), 34.0% declining for anticipated weight gain of 5.0–9.1 kg (11–20 lb), and 52.4% declining for anticipated weight gain greater than 9 kg (20 lbs). CONCLUSION: Patients living with schizophrenia spectrum disorders are influenced by many factors when considering whether to take their medication, including efficacy and side effects. It is important for clinicians to assess specific patient concerns to develop a comprehensive treatment plan that maximizes adherence to the prescribed therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12888-018-1856-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-12 /pmc/articles/PMC6142379/ /pubmed/30223804 http://dx.doi.org/10.1186/s12888-018-1856-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Achtyes, Eric Simmons, Adam Skabeev, Anna Levy, Nikki Jiang, Ying Marcy, Patricia Weiden, Peter J. Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia |
title | Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia |
title_full | Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia |
title_fullStr | Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia |
title_full_unstemmed | Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia |
title_short | Patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia |
title_sort | patient preferences concerning the efficacy and side-effect profile of schizophrenia medications: a survey of patients living with schizophrenia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142379/ https://www.ncbi.nlm.nih.gov/pubmed/30223804 http://dx.doi.org/10.1186/s12888-018-1856-y |
work_keys_str_mv | AT achtyeseric patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia AT simmonsadam patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia AT skabeevanna patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia AT levynikki patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia AT jiangying patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia AT marcypatricia patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia AT weidenpeterj patientpreferencesconcerningtheefficacyandsideeffectprofileofschizophreniamedicationsasurveyofpatientslivingwithschizophrenia |